BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 26997641)

  • 1. Anti-peptidyl-arginine deaminase 3 (PAD3) antibodies as a promising marker to measure joint damage in patients with rheumatoid arthritis.
    Seaman A; Darrah E; Infantino M; Meacci F; Manfredi M; Benucci M; Mahler M
    Autoimmun Rev; 2016 Jul; 15(7):776-80. PubMed ID: 26997641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of anti-peptidyl arginine deiminase antibodies with radiographic severity of rheumatoid arthritis in African Americans.
    Navarro-Millán I; Darrah E; Westfall AO; Mikuls TR; Reynolds RJ; Danila MI; Curtis JR; ; Rosen A; Bridges SL
    Arthritis Res Ther; 2016 Oct; 18(1):241. PubMed ID: 27770831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of cross-reactive antibodies targeting peptidyl-arginine deiminase 3 and 4 with rheumatoid arthritis-associated interstitial lung disease.
    Giles JT; Darrah E; Danoff S; Johnson C; Andrade F; Rosen A; Bathon JM
    PLoS One; 2014; 9(6):e98794. PubMed ID: 24901704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantibodies to Peptidylarginine Deiminase 2 Are Associated With Less Severe Disease in Rheumatoid Arthritis.
    Darrah E; Giles JT; Davis RL; Naik P; Wang H; Konig MF; Cappelli LC; Bingham CO; Danoff SK; Andrade F
    Front Immunol; 2018; 9():2696. PubMed ID: 30515171
    [No Abstract]   [Full Text] [Related]  

  • 5. Anti-peptidylarginine deiminase-4 antibodies at mucosal sites can activate peptidylarginine deiminase-4 enzyme activity in rheumatoid arthritis.
    Demoruelle MK; Wang H; Davis RL; Visser A; Hoang J; Norris JM; Holers VM; Deane KD; Darrah E
    Arthritis Res Ther; 2021 Jun; 23(1):163. PubMed ID: 34092252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-CarP antibodies as promising marker to measure joint damage and disease activity in patients with rheumatoid arthritis.
    Yee A; Webb T; Seaman A; Infantino M; Meacci F; Manfredi M; Benucci M; Lakos G; Favalli E; Schioppo T; Meroni PL; Mahler M
    Immunol Res; 2015 Feb; 61(1-2):24-30. PubMed ID: 25391608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-protein arginine deiminase antibodies are distinctly associated with joint and lung involvement in rheumatoid arthritis.
    Palterer B; Vitiello G; Del Carria M; D'Onofrio B; Martinez-Prat L; Mahler M; Cammelli D; Parronchi P
    Rheumatology (Oxford); 2023 Jul; 62(7):2410-2417. PubMed ID: 36440916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smoking is not linked to the development of anti-peptidylarginine deiminase 4 autoantibodies in rheumatoid arthritis.
    Cappelli LC; Konig MF; Gelber AC; Bingham CO; Darrah E
    Arthritis Res Ther; 2018 Mar; 20(1):59. PubMed ID: 29566742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative analysis of autoantibodies targeting peptidylarginine deiminase type 4, mutated citrullinated vimentin and cyclic citrullinated peptides in rheumatoid arthritis: associations with cytokine profiles, clinical and genetic features.
    Reyes-Castillo Z; Palafox-Sánchez CA; Parra-Rojas I; Martínez-Bonilla GE; del Toro-Arreola S; Ramírez-Dueñas MG; Ocampo-Bermudes G; Muñoz-Valle JF
    Clin Exp Immunol; 2015 Nov; 182(2):119-31. PubMed ID: 26149185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Affinity maturation shapes the function of agonistic antibodies to peptidylarginine deiminase type 4 in rheumatoid arthritis.
    Shi J; Darrah E; Sims GP; Mustelin T; Sampson K; Konig MF; Bingham CO; Rosen A; Andrade F
    Ann Rheum Dis; 2018 Jan; 77(1):141-148. PubMed ID: 29070531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive value of anti-CarP and anti-PAD3 antibodies alone or in combination with RF and ACPA for the severity of rheumatoid arthritis.
    Lamacchia C; Courvoisier DS; Jarlborg M; Bas S; Roux-Lombard P; Möller B; Ciurea A; Finckh A; Bentow C; Martinez-Prat L; Mahler M; Gabay C; Nissen MJ;
    Rheumatology (Oxford); 2021 Oct; 60(10):4598-4608. PubMed ID: 33502443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erosive rheumatoid arthritis is associated with antibodies that activate PAD4 by increasing calcium sensitivity.
    Darrah E; Giles JT; Ols ML; Bull HG; Andrade F; Rosen A
    Sci Transl Med; 2013 May; 5(186):186ra65. PubMed ID: 23698378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and immunological aspects of anti-peptidylarginine deiminase type 4 (anti-PAD4) autoantibodies in rheumatoid arthritis.
    Reyes-Castillo Z; Muñoz-Valle JF; Llamas-Covarrubias MA
    Autoimmun Rev; 2018 Feb; 17(2):94-102. PubMed ID: 29196243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of anti-peptidylarginine deiminase type 4 antibodies in rheumatoid arthritis and unaffected first-degree relatives in indigenous North American Populations.
    Ferucci ED; Darrah E; Smolik I; Choromanski TL; Robinson DB; Newkirk MM; Fritzler MJ; Rosen A; El-Gabalawy HS
    J Rheumatol; 2013 Sep; 40(9):1523-8. PubMed ID: 23908443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptidyl-arginine deiminase: an additional marker of rheumatoid arthritis.
    Basu PS; Majhi R; Ghosal S; Batabyal SK
    Clin Lab; 2011; 57(11-12):1021-5. PubMed ID: 22239037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum antibodies to peptidylarginine deiminase-4 in rheumatoid arthritis associated-interstitial lung disease are associated with decreased lung fibrosis and improved survival.
    Wilson TM; Solomon JJ; Humphries SM; Swigris JJ; Ahmed F; Wang H; Darrah E; Demoruelle MK
    Am J Med Sci; 2023 Jun; 365(6):480-487. PubMed ID: 36918112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Citrullination of synovial proteins in murine models of rheumatoid arthritis.
    Vossenaar ER; Nijenhuis S; Helsen MM; van der Heijden A; Senshu T; van den Berg WB; van Venrooij WJ; Joosten LA
    Arthritis Rheum; 2003 Sep; 48(9):2489-500. PubMed ID: 13130468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heavy Chain Constant Region Usage in Antibodies to Peptidylarginine Deiminase 4 as a Marker of Disease Subsets in Rheumatoid Arthritis.
    Gómez-Bañuelos E; Shi J; Wang H; Danila MI; Bridges SL; Giles JT; Sims GP; Andrade F; Darrah E
    Arthritis Rheumatol; 2022 Nov; 74(11):1746-1754. PubMed ID: 35675168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autophagy generates citrullinated peptides in human synoviocytes: a possible trigger for anti-citrullinated peptide antibodies.
    Sorice M; Iannuccelli C; Manganelli V; Capozzi A; Alessandri C; Lococo E; Garofalo T; Di Franco M; Bombardieri M; Nerviani A; Misasi R; Valesini G
    Rheumatology (Oxford); 2016 Aug; 55(8):1374-85. PubMed ID: 27074807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoimmunity to peptidyl arginine deiminase type 4 precedes clinical onset of rheumatoid arthritis.
    Kolfenbach JR; Deane KD; Derber LA; O'Donnell CI; Gilliland WR; Edison JD; Rosen A; Darrah E; Norris JM; Holers VM
    Arthritis Rheum; 2010 Sep; 62(9):2633-9. PubMed ID: 20496417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.